46.46.Z - Wholesale trade of pharmaceutical and medical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
47.74.Z - Retail sale of medical and orthopedic products
47.99.Z - Retail trade
52.10.B - Warehousing and storage of other goods
68.10.Z - Real estate activities on own account and development of building projects
72.11.Z - Scientific research and development activities
72.19.Z - Scientific research and development activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 6,9 | 307,9 | ||
Gross profit (loss) | 6,8 | 10,9 | 2,8 | -74,1 |
EBITDA | 7,2 | 11,1 | 3,1 | -72,1 |
Short time liabilities | 0,6 | 0,1 | 2,3 | 1898,7 |
Other operating costs | 0,1 | -60,2 | ||
Equity capital | 8,9 | 17,7 | 20 | 12,8 |
Operating profit (EBIT) | 7 | 11 | 3 | -72,8 |
Assets | 10,6 | 18,5 | 22,9 | 23,7 |
Net profit (loss) | 5,6 | 8,8 | 2,3 | -74,4 |
Cash | 3,9 | 6,8 | 3,8 | -43,9 |
Liabilities and provisions for liabilities | 1,7 | 0,8 | 2,9 | 278,6 |
Net income from sale | 19,5 | 33,9 | 16,3 | -51,9 |
Working assets | 7,5 | 12,1 | 14,5 | 19,7 |
Other income costs | 0,1 | 324,4 | ||
Depreciation | 0,2 | 0,1 | 0,1 | -9,7 |
% | % | % | p.p. | |
Profitability of capital | 63 | 49,9 | 11,3 | -38,6 |
Equity capital to total assets | 84,1 | 95,9 | 87,4 | -8,5 |
Gross profit margin | 34,8 | 32,3 | 17,4 | -14,9 |
EBITDA Margin | 36,8 | 32,9 | 19,1 | -13,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 11 | 1 | 51 | 50 |
Current financial liquidity indicator | 13.135671615600586 | 10,3 | ||
Net dept to EBITDA | -0.5460099577903748 | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane